Skip to main content

Table 1 Associations of miR-196a and/or miR-196b expression with the clinicopathological characteristics of colorectal cancer

From: Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer

Clinical features

Case number (%)

miR-196a-high

miR-196b-high

miR-196a-high/miR-196b-high

(N, %)

P

(N, %)

P

(N, %)

P

Gender

       

Male

76 (60.32)

46 (60.53)

NS

48 (63.16)

NS

31 (40.79)

NS

Female

50 (39.68)

30 (60.00)

30 (60.00)

21 (42.00)

Age (years)

       

<66

48 (30.10)

28 (58.33)

NS

28 (58.33)

NS

21 (43.75)

NS

≥66

78 (69.90)

48 (61.54)

50 (64.10)

31 (39.74)

Site of primary tumor

       

Right-sided

48 (38.10)

30 (62.50)

NS

30 (62.50)

NS

20 (41.67)

NS

Left-sided

46 (36.51)

28 (60.87)

28 (60.87)

20 (43.48)

Rectum

32 (25.40)

18 (56.25)

20 (62.50)

12 (37.50)

Tumor size (cm)

       

<5

70 (55.56)

40 (57.14)

NS

42 (60.00)

NS

30 (42.86)

NS

≥5

56 (44.44)

36 (64.29)

36 (64.29)

22 (39.29)

Depth of tumor invasion

       

T1-T2

47 (37.30)

26 (55.32)

NS

28 (59.57)

NS

20 (42.55)

NS

T3-T4

79 (62.70)

50 (63.29)

50 (63.29)

32 (40.51)

Lymph node metastasis

       

Negative

68 (53.97)

24 (35.29)

0.01

26 (38.24)

0.01

12 (17.65)

0.008

Positive

58 (46.03)

52 (89.66)

52 (89.66)

40 (68.97)

TNM stage

       

I

13 (10.32)

0 (0)

0.006

0 (0)

0.006

0 (0)

<0.001

II

46 (36.51)

20 (43.48)

22 (47.83)

10 (18.87)

III

50 (39.68)

39 (78.00)

39 (78.00)

25 (50.00)

IV

17 (13.49)

17 (100.00)

17 (100.00)

17 (100.00)

Histological grade

       

Well/moderately

80 (63.49)

40 (50.00)

0.02

40 (50.00)

0.02

22 (27.50)

0.01

Poorly

46 (36.51)

36 (78.26)

38 (82.61)

30 (65.22)

  1. Note: ‘NS’ refers to the difference without statistical significance.